Aliskiren Hemifumarate
4 NDCs across 2 manufacturers|2 Generic,2 Brand
Aliskiren Hemifumarate is used to treat hypertension, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 5, 2007, and the first generic was approved Mar 22, 2019. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $10 million on Aliskiren Hemifumarate across 31,000 claims for 7,150 beneficiaries.
Aliskiren Hemifumarate is available as 4 NDCs from 2 manufacturers (2 generic, 2 brand), with NADAC prices from $4.05 to $15.09 per EA — the most expensive product costs about 3.7× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
2G / 2B
Manufacturers
2
competing in market
Price Spread
$4.05 – $15.09
per EA
7d Activity
avg +0.2% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing ALISKIREN HEMIFUMARATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TEKTURNA 300 MG TABLET | $15.0945 per EA | — |
TEKTURNA 150 MG TABLET | $11.0782 per EA | — |
ALISKIREN 300 MG TABLET | $5.7183 per EA | +1.13% |
ALISKIREN 150 MG TABLET | $4.0474 per EA | -0.68% |
Frequently Asked Questions
What is Aliskiren Hemifumarate used to treat?
Aliskiren Hemifumarate is used to treat hypertension, per the National Library of Medicine's MED-RT classification.
When did Aliskiren Hemifumarate become available as a generic?
FDA approved the first generic Aliskiren Hemifumarate (ANDA) on Mar 22, 2019. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Aliskiren Hemifumarate?
In 2024, Medicare Part D spent $10 million on Aliskiren Hemifumarate across 31,000 claims for 7,150 beneficiaries.
How many Aliskiren Hemifumarate products are on the market?
The Aliskiren Hemifumarate drug market contains 4 NDCs from 2 manufacturers — 2 generic and 2 brand products.
What is the price range for Aliskiren Hemifumarate?
NADAC reference prices for Aliskiren Hemifumarate range from $4.0474 to $15.0945 per EA — the most expensive product costs about 3.7× the cheapest.
Is generic Aliskiren Hemifumarate cheaper than brand?
The average generic NADAC for Aliskiren Hemifumarate is $4.8828 per EA, versus $13.0863 for brand-labeled products — brand versions average about 2.7× the generic price.
Which manufacturers make Aliskiren Hemifumarate?
2 manufacturers list Aliskiren Hemifumarate in NADAC. Ranked by number of NDCs, the largest are LXO US Inc. (2), Prasco Laboratories (2).
How has the price of Aliskiren Hemifumarate changed recently?
Over the past 7 days, 1 Aliskiren Hemifumarate NDC rose and 1 fell, with a market-wide average change of +0.2%.